Bradley L. Radoff Announces Intent to Withhold Votes from Chair and CEO William Greenman and Director Ann Lucena

About this update from Cerus Corporation

[{"type":"text","content":"HOUSTON, May 27, 2026--(BUSINESS WIRE)--Bradley L. Radoff, a significant shareholder of Cerus Corporation (NASDAQ: CERS) ("Cerus" or the "Company"), today announced his intention to withhold support for the Company’s two director nominees at the upcoming 2026 annual meeting in the below open letter to shareholders.","length":336,"tagName":"p"},{"type":"text","content":"***","length":3,"tagName":"p","attribs":{}},{"type":"text","content":"May 27, 2026","length":12,"tagName":"p","attribs":{}},{"type":"text","content":"Fellow Shareholders,","length":20,"tagName":"p"},{"type":"text","content":"I am an individual shareholder in Cerus managing my own capital. In light of the Company’s negative returns and failure to achieve profitability over the past decade, I will be withholding my votes from the reelection of William Greenman, the Chair of the Board of Directors (the "Board") and CEO of Cerus, and Ann Lucena, the Chair of the Board’s Compensation Committee at the 2026 annual meeting scheduled for June 2, 2026.","length":435,"tagName":"p"},{"type":"text","content":"Why I Am Withholding Support for Cerus’ Directors at the 2026 Annual Meeting:","length":77,"tagName":"p"},{"type":"text","content":"1. Under Mr. Greenman’s leadership, Cerus has failed to create value for shareholders despite having a market-leading product in the INTERCEPT Blood System. Over the past 10 years, Cerus has delivered a (50.8%) return.1","length":219,"tagName":"p","attribs":{}},{"type":"text","content":"2. Over the past decade, Cerus’ share count has nearly doubled, increasing from 101,710,815 in March 2016 to 200,316,000 in March 2026.2 This stock dilution has offset the growth of the business, with the Company continuing to deliver an annual net loss. The Board has continued to increase the number of shares available for the grant of equity awards to executives and directors – even as shareholders have voiced opposition to this decision.","length":444,"tagName":"p","attribs":{}},{"type":"text","content":"a. At the 2023 annual meeting, 43.5% of shareholders voted against the amendment and restatement of the Company’s equity incentive plan to increase the share count by 7 million shares.3 Despite this, the Board put forth similar proposals in 2024 and 2025 to increase the aggregate number of shares of common stock authorized for ...

More updates from Cerus Corporation